Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel

BACKGROUND: Management of schizophrenia is sub-optimal in many patients. Targeting negative symptoms, among the most debilitating aspects of schizophrenia, together with positive symptoms, can result in significant functional benefits and dramatically improve quality of life for patients and their c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagiolini, Andrea, Alcalá, José Ángel, Aubel, Thomas, Bienkiewicz, Wojciech, Bogren, Mats Magnus Knut, Gago, Joaquim, Cerveri, Giancarlo, Colla, Michael, Sanchez, Francisco Collazos, Cuomo, Alessandro, Helge, Frieling, Iacoponi, Eduardo, Karlsson, Per-Axel, Peddu, Pradeep, Pettorruso, Mauro, Pereira, Henrique Jorge Ramos, Schölin, Johan Sahlsten, Vernaleken, Ingo Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520022/
https://www.ncbi.nlm.nih.gov/pubmed/32999683
http://dx.doi.org/10.1186/s12991-020-00305-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520022/
https://www.ncbi.nlm.nih.gov/pubmed/32999683
http://dx.doi.org/10.1186/s12991-020-00305-3

Ejemplares similares